A phase 1/2a, dose-escalation, safety, pharmacokinetic, and preliminary efficacy study of intraperitoneal administration of BC-819 (H19-DTA) in subjects with recurrent ovarian/peritoneal cancer
Titel:
A phase 1/2a, dose-escalation, safety, pharmacokinetic, and preliminary efficacy study of intraperitoneal administration of BC-819 (H19-DTA) in subjects with recurrent ovarian/peritoneal cancer
Auteur:
Lavie, Ofer Edelman, David Levy, Tally Fishman, Ami Hubert, Ayala Segev, Yakir Raveh, Eli Gilon, Michal Hochberg, Avraham